New study uncovers how gliomas disrupt brain function and points to rapid therapeutic reversal

A study led by Dr. Peter Canoll’s lab, in collaboration with researchers at Columbia University Irving Medical Center, Zuckerman Institute, and Irving Institute for Cancer Dynamics, along with multiple other researchers at other universities, provides novel insights into how gliomas—aggressive brain tumors—cause debilitating neurological symptoms such as seizures and cognitive impairments.